Symposium Developments and Controversies in Thyroid Cancer

This symposium will provide an update on the management of recurrent primarily differentiated thyroid cancer by focusing on the understanding of the latest evidence on:

  • Molecular and cellular predictors of recurrent thyroid cancer
  • Evaluation and work up of patients with recurrent thyroid cancer
  • Surgical approaches to recurrent thyroid cancer in the primary site, neck and distant sites
  • The use of non-surgical treatment for recurrent thyroid cancer
  • To understand the current evidence and controversies to support clinical practice decision making

The symposium is targeted to all members of the thyroid multidisciplinary teams treating thyroid cancer including qualified staff and trainees. These include Surgeons, Endocrinologists, Nuclear Physicians, Oncologists, Clinical Nurse Specialists, and Speech and Language Therapists.


More information in the official flyer.